(Q37844406)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24792993%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

title

Recent advances in technologies for developing drugs against Chlamydia pneumoniae (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24792993%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Chlamydia pneumoniae

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24792993%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Pia M Vuorela

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24792993%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

language of work or name

English

0 references

publication date

3 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24792993%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Discovery

17 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24792993%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24792993%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24792993%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

page(s)

791-802

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24792993%20AND%20SRC:MED&resulttype=core&format=json

Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease

17 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Infection, antibiotics, and atherothrombosis--end of the road or new beginnings?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Chlamydia pneumoniae as a respiratory pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Is asthma an infectious disease? New evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Chlamydia pneumoniae: possible association with asthma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Chlamydophila pneumoniae infection and COPD: more evidence for lack of evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Chlamydia and chronic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Antibiotics, peptidoglycan synthesis and genomics: the chlamydial anomaly revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Another brick in the wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Penicillin induced persistence in Chlamydia trachomatis: high quality time lapse video analysis of the developmental cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

The intracellular life of chlamydiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Chlamydial persistence: beyond the biphasic paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Molecular pathogenesis of chronic Chlamydia pneumoniae infection: a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Dendrimer-enabled DNA delivery and transformation of Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Molecular evidence for the existence of additional members of the order Chlamydiales

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

New parachlamydial 16S rDNA phylotypes detected in human clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Chlamydia-like bacteria in respiratory samples of community-acquired pneumonia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Parachlamydia acanthamoebae, an emerging agent of pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Treatment of chlamydial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Therapeutic approaches to Chlamydia infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Effect of levofloxacin on the viability of intracellular Chlamydia pneumoniae and modulation of proinflammatory cytokine production by human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Elderly patients with community-acquired pneumonia: optimal treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

First-choice antibiotics at subinhibitory concentrations induce persistence of Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Are natural products still the best source for antibacterial discovery? The bacterial entry factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

The 2012 Garrod lecture: discovery of antibacterial drugs in the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Development and validation of a time-resolved fluorometric immunoassay for screening of antichlamydial activity using a genus-specific europium-conjugated antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Inhibitory effect of dietary phenolic compounds on Chlamydia pneumoniae in cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Design and synthesis of 2-arylbenzimidazoles and evaluation of their inhibitory effect against Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Inhibitory effect of the natural product betulin and its derivatives against the intracellular bacterium Chlamydia pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

N-acylated derivatives of sulfamethoxazole and sulfafurazole inhibit intracellular growth of Chlamydia trachomatis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Macrophage L-type Ca2+ channel antagonists alter Chlamydia pneumoniae MOMP and HSP-60 mRNA gene expression, and improve antibiotic susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Effects of coadministration of natural polyphenols with doxycycline or calcium modulators on acute Chlamydia pneumoniae infection in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

In vivo treatment of acute Chlamydia pneumoniae infection with the flavonoids quercetin and luteolin and an alkyl gallate, octyl gallate, in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Corn mint (Mentha arvensis) extract diminishes acute Chlamydia pneumoniae infection in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Effect of simvastatin, an established lipid-lowering drug, on pulmonary Chlamydia pneumoniae infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Effect of pravastatin treatment on Chlamydia pneumoniae infection, inflammation and serum lipids in NIH/S mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Simvastatin reduces Chlamydophila pneumoniae-mediated histone modifications and gene expression in cultured human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Induced expression of lectin-like oxidized ldl receptor-1 in vascular smooth muscle cells following Chlamydia pneumoniae infection and its down-regulation by fluvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Rapamycin can inhibit the development of Chlamydia pneumoniae, which might partly contribute to the prevention of in-stent restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Inhibitory effect of heparan sulfate-like glycosaminoglycans on the infectivity of Chlamydia pneumoniae in HL cells varies between strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Retinoic acid inhibits the infectivity and growth of Chlamydia pneumoniae in epithelial and endothelial cells through different receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

New frontiers in type III secretion biology: the Chlamydia perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Targeting bacterial virulence: inhibitors of type III secretion in Yersinia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Exploration of chlamydial type III secretion system reconstitution in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Small molecule inhibitors of the Yersinia type III secretion system impair the development of Chlamydia after entry into host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Pre-clinical pharmacokinetics and anti-chlamydial activity of salicylidene acylhydrazide inhibitors of bacterial type III secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Chlamydia Pneumoniae CdsL Regulates CdsN ATPase Activity, and Disruption with a Peptide Mimetic Prevents Bacterial Invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Exploiting Antigenic Diversity for Vaccine Design: THE CHLAMYDIA ArtJ PARADIGM

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Structural analysis and serological test of arginine periplasmic binding protein 2 from Chlamydophila pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Insight into disulfide bond catalysis in Chlamydia from the structure and function of DsbH, a novel oxidoreductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Structural characterization of a novel Chlamydia pneumoniae type III secretion-associated protein, Cpn0803

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Conformation study of 2-arylbenzimidazoles as inhibitors of Chlamydia pneumoniae growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Gene expression profiles of Chlamydophila pneumoniae during the developmental cycle and iron depletion-mediated persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

The transcript profile of persistent Chlamydophila (Chlamydia) pneumoniae in vitro depends on the means by which persistence is induced

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Genome and proteome analysis of Chlamydia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Action and reaction: Chlamydophila pneumoniae proteome alteration in a persistent infection induced by iron deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Proteome analysis of the Chlamydia pneumoniae elementary body

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Characterization of a secreted Chlamydia protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Secretion of Cpn0796 from Chlamydia pneumoniae into the host cell cytoplasm by an autotransporter mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Host cell responses to Chlamydia pneumoniae in gamma interferon-induced persistence overlap those of productive infection and are linked to genes involved in apoptosis, cell cycle, and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Microarray analysis of a Chlamydia pneumoniae-infected human epithelial cell line by use of gene ontology hierarchy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Proteomic analysis of Chlamydia pneumoniae-infected HL cells reveals extensive degradation of cytoskeletal proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

CPAF: a Chlamydial protease in search of an authentic substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Transformation and isolation of allelic exchange mutants of Chlamydia psittaci using recombinant DNA introduced by electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Virulence determinants in the obligate intracellular pathogen Chlamydia trachomatis revealed by forward genetic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

How were new medicines discovered?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Drugs for bad bugs: confronting the challenges of antibacterial discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

Platforms for antibiotic discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.915309

10.1517/17460441.2014.915309

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24792993%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference